Advertisement

acoustic neuroma.pptx

Mar. 23, 2023
Advertisement

More Related Content

Advertisement

acoustic neuroma.pptx

  1. ACOUSTIC NEUROMA Dr. Asha K Joy 15/03/23
  2. Specific learning objectives • Describe in brief CP angle anatomy and tumours • Enumerate pathogenesis, clinical features of acoustic neuroma • Enumerate radiological, audiological and pathological investigations for acoustic neuromas • Enumerate treatment guidelines
  3. DEFINITION • Benign tumor of vestibular nerve schwann cells
  4. VESTIBULAR SCHWANNOMA • 6 % of all Intracranial tumors • 80 - 90% of CPA tumors • Majority adulthood • 95% Unilateral • 5% Neurofibromatosis type 2 (bilateral) • No known race, gender predilection
  5. ANATOMY OF CPANGLE • Triangular area Posterior surface of temporal bone Edge of pons Anterior surface of cerebellum Trigeminal nerve • Lateral • Medial • Posterior • Superior • Inferior IX, X, XI cranial nerves
  6. Anatomy of CPA ⚫ AICA is the main artery in the CPA and is the source of the labrynthine artery . ⚫ The labrynthine artery courses via the IAC & is an end artery for the hearing and balance organs.
  7. SITE OF ORIGIN • Schwann cells which envelop distal potion of VIIIth nerve • More common from inferior vestibular nerve • Arise from schwann cells within the IAC – lateral to O-R zone in the area of scarpa ganglion. • Schwannomas rarely arise from the cochlear nerve & are rarely malignant .
  8. EFFECTS ON INNER EAR • Compressive effect on cochlear nerve • Vascular occlusion of internal auditory artery • Atrophy of organ of Corti • Vacuolization of stria vascularis
  9. Pathogenesis • Owing to mutations in the gene for the tumor suppresor protein MERLIN located on chr 22q12. • Formation of VS requires mutation of both copies of the merlin gene. • Somatic mutations in both copies of merlin gene results in sporadic VSs . • Familial VS occuring in NF 2 requires only one somatic mutation event .( inherit one )
  10. • NF2 is autosomal recessive at gene level but inheritance is autosomal dominant ( pseudodominant ) • A mutation in the normal allele leads to bilateral VS by the age of 20. • Genetic screens for the NF2 mutation have been developed and are the basis for genetic counselling for family members of NF2 patients
  11. • Biochemical factors- VS express neuregulin ,which controls survival and proliferation of schwann cells and its receptors erbB2 & erbB3. • FGF ,TGF B1 , PDGF & VEGF all these contribute to VS proliferation. • VS may accelerate during pregnancy.
  12. Pathology GROSS : • VS have a smooth surface with a yellow to gray color. • Tumor is usually solid ,with occasional cystic components and therefore has a firm to soft texture depending on solid to cystic components. MICROSCOPIC : • Capsule – 3 to 5 micrometer in thickness. • Two morphological tissue types – Antony A & Antony B areas
  13. GROWTH PATTERN • Grows medially • Invested by double arachnoid layer
  14. 1. 2. 3. 4. INTRACANALICULAR CISTERNAL COMPRESSIVE HYDROCEPHALIC
  15. STAGES (< 2 cm) 1 Otological stage (<2cm) 2 Trigeminal nerve involvement (2-2.5 cm) 3 Brain stem and cerebellar compression (2.5-4 cm) 4 Increasing intracranial pressure (>4 cm) 5 Terminal stage
  16. STAGE 1 OTOLOGICAL STAGE • Deafness – Unilateral, gradual • Tinnitus – Non-pulsatile • Imbalance • Trigeminal nerve involvement • Facial nerve involvement
  17. STAGE 2 TRIGEMINAL NERVE INVOLVEMENT • Tumor size 2-2.5 cm • Irritation in eye • Pain, tingling, numbness on face • Feeling of cold on face
  18. STAGE 3 BRAIN STEM AND CEREBELLAR COMPRESSION • Ataxia • Gait disturbance • Tremors • Nystagmus
  19. STAGE 4 INCREASING INTRACRANIAL PRESSURE • Headache occipital • Nausea Vomiting • Papilloedema
  20. STAGE 5 TERMINAL STAGE • Failure of vital centres in brain stem
  21. EXAMINATION • Cutaneous lesions (neurofibromas) • Otoscopy: Normal • Tuning fork tests: – Unilateral senorineural deafness • Trigeminal Nerve • Facial nerve • Eye examination
  22. EXAMINATION • Finger nose test • Romberg’s test • Unterberg’s test
  23. Diagnostic evaluation • Average patient will require 4 years from the onset of symptoms to diagnosis. • Majority will present with complaints of UHL, UT, Vertigo , dysequilibrium, facial numbness, weakness or spasm. • Initial step in evaluation includes an audiologic assessment .if it suggests a retrocochlear lesion , then imaging of the CPA is performed . • Vestibular testing lacks specificity in diagnosis of VS
  24. INVESTIGATIONS • Speech test • Speech audiometry • PTA • Stapedial reflex • Electrocochleography • ABR • Caloric test
  25. BERA patterns in AN
  26. RADIOLOGICAL INVESTIGATIONS • Temporal bone radiology (contrast))
  27. CT-SCAN WITH CONTRAST
  28. DIFFERENTIAL DIAGNOSIS • Meningioma • Primary cholesteatoma • Arachnoid cysts • Facial neuromas • Lipoma • Choroid plexus papilloma • Glomus jugulare
  29. TREATMENT • Surgery • Observation • Radiotherapy – Conventional – Stereotactic
  30. STEREOTACTIC RADIOSURGERY Indications • Patient who is poor surgical risk (age, medical condition, etc.) • Tumor < 3 cm • Younger patients with < 3 cm tumor who refuse surgery
  31. SURGERY • Middle fossa approach • Translabyrinthine approach • Retrosigmoid approach
  32. Middle Fossa Approach. Translabyrinthine Approach SuboccipitalApproach Surgical Approaches Factors that influence surgical approach selection •Age •Hearing status •Tumour size •Surgeon’s preference.
  33. CONSERVATIVE MANAGEMENT • Advanced age (> 65 ) • Short life expectancy (< 10 years) • Slow growth rate • Poor surgical candidate / poor general health • Minimal symptoms • Only hearing ear • Patience preference
  34. Thank you
Advertisement